Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse
neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract …

Objective Neuroendocrine tumors of the gynecologic tract are rare, and pose a significant
clinical challenge because of the tumor heterogeneity and lack of standardized guidelines …

Therapeutic approaches for management of metastatic disease include surgical, medical,
radiological and nuclear medicine strategies. More recently, novel molecular targeted drugs …

Neuroendocrine tumors (NETs) comprise a broad family of tumors that may or may not be
associated with symptoms attributable to hormonal hypersecretion. The NCCN Clinical …

The WHO 2010 classification [1] distinguishes between well-differentiated neuroendocrine
tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) of small or …

Molecular radiotherapy (MRT) has demonstrated unique therapeutic advantages in the
treatment of an increasing number of cancers. As with other treatment modalities, there is …

The past decade has seen significant advancement in the locoregional management of liver
tumors; novel and promising therapies such as transarterial chemoembolization …

Objectives Liver metastasis from a neuroendocrine tumour (NET) represents a significant
clinical entity. A multidisciplinary group of experts was convened to develop state-of-the-art …

Radioembolization (RE) of liver cancer with 90Y-microspheres has been applied in the last
two decades with notable responses and acceptable toxicity. Two types of microspheres are …

Limited therapeutic options are available for hepatic malignancies. Image guided targeted
therapies have established their role in management of primary and secondary hepatic …